INSIGHTS ON DRUG DEVELOPMENT
-
Is Industry Ready To Take A Bite Out Of Obesity?
What are the clinical, economic, and policy considerations for a class of drugs offering a promising treatment for obesity, and how is the industry adapting to meet demand?
-
MAPK Signaling Pathway
Mitogen-activated protein kinase cascades regulate key cellular processes like proliferation, differentiation, and apoptosis. Explore how these pathways maintain cellular homeostasis and contribute to disease development.
-
AI-Enabled Phenotypic Analysis Of Label-Free Intestinal Organoids
Discover how advanced 3D models and AI-enabled imaging techniques revolutionize organoid research, which provides accurate phenotypic analysis to monitor growth and development in various organoid types.
-
Bioanalytical Quantification Of A Biotherapeutic Peptide
Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.
-
Five Practical Considerations To Move From Concept To Clinic12/17/2025
Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.
-
White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges10/16/2024
Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.
-
Nanomedicine Modalities Find Path To Clinic Through Analytics5/16/2025
Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.
-
Duodenum Intestine-Chip For Modeling Human Physiology3/14/2024
Discover an Intestine-Chip that integrates the robust cell sourcing of organoids with Organs-on-Chips technology to overcome experimental limitations and yield a closer-to-human transcriptomic profile.
-
Improving In Vitro Cancer Modeling8/2/2024
Organ-on-a-Chip technology represents a significant advancement in drug discovery. By mimicking human physiology, Organ-Chips can enhance the predictive accuracy of preclinical models and accelerate drug development.
DRUG DEVELOPMENT SOLUTIONS
-
Gain human-relevant insights with patient-derived assay-ready organoids.
-
Explore an approach that accelerates your project through key milestones with a technology transfer process that ensures a fast start and process analytical technology that increases efficiency and reduces cost.
-
Leica DM3000
Enhance Laboratory Workflow
The Leica DM3000 microscopes for pathology, cytology, haematology and many other applications feature a motorized nosepiece, condenser head, automated light intensity adjustment, and optional foot pedal. These intuitive microscopes improve workflows significantly. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).
-
Overcome shared lab challenges with the Avanti JXN-30 high-speed centrifuge
- 4.0 L Max Capacity
- 30,000 RPM
- 110,510 x g
-
Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.